CompletedNCT02637401
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- Bipolarity
CompletedNCT03131505
This study exists to improve how questionnaires and follow-up reports can help identify, measure, or follow care over time. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Norfolk and Suffolk NHS Foundation Trust
- Condition
- Schizophrenia
CompletedNCT00908154
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- Biogen
- Condition
- Bipolarity
CompletedNCT00488566
This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Biogen
- Condition
- Bipolarity
TerminatedNCT00483535
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United Kingdom
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity
CompletedNCT00501865
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity
CompletedNCT02212041
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT02804867
This study exists to improve how questionnaires and follow-up reports can help identify, measure, or follow care over time. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Cambridge
- Condition
- Depression
CompletedNCT00459264
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
BipolarityOtherFrom 14 Years to 24 Years
- Countries
- United Kingdom
- Sponsor
- University of Oxford
- Condition
- Bipolarity
TerminatedNCT01677182
This study exists to explore whether the medication Ramelteon could improve care and understanding. Researchers are trying to understand whether the medication Ramelteon can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 75 Years
- Countries
- Bulgaria, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, United States
- Sponsor
- Takeda
- Condition
- Bipolarity
CompletedNCT01981018
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Medical Research Council Cognition and Brain Sciences Unit
- Condition
- Bipolarity
CompletedNCT01315028
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- NHS Greater Glasgow and Clyde
- Condition
- Bipolarity
RecruitingNCT07553637
This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- United Kingdom, United States
- Sponsor
- Alto Neuroscience
- Condition
- Depression
CompletedNCT05202119
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
DepressionOtherOver 18 Years
- Countries
- United Kingdom, United States
- Sponsor
- Flow Neuroscience AB
- Condition
- Depression
Not Yet RecruitingNCT07529886
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
AnxietyOtherOver 65 Years
- Countries
- United Kingdom
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Condition
- Anxiety
CompletedNCT05550532
This study exists to understand what helps the medication Aticaprant work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to the medication Aticaprant in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Brazil, Bulgaria, Canada, China, Czech Republic, France, Poland, Slovakia, South Africa, South Korea, Taiwan, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
CompletedNCT07272096
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
AnxietyOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Swansea University
- Condition
- Anxiety
CompletedNCT07253324
This study exists to better understand the safety of the medication ENX-104 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication ENX-104 in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Engrail Therapeutics INC
- Condition
- Depression
CompletedNCT06309277
This study exists to see whether the medication GM-1020 is workable and worth testing more broadly. For people living with Depression, that matters because care needs to work in daily life, not just in theory.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Gilgamesh Pharmaceuticals
- Condition
- Depression
TerminatedNCT04708834
This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with Mental health, that matters because care needs to work in daily life, not just in theory.
Mental healthOtherFrom 18 Years to 65 Years
- Countries
- Canada, Italy, Netherlands, Spain, United Kingdom, United States
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Condition
- Mental health
CompletedNCT06693609
This study exists to compare options and see whether the medication EMP-01 offers something meaningfully different. Researchers are trying to understand how people respond to the medication EMP-01 in practice and what may need to be adjusted.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- atai Therapeutics, Inc.
- Condition
- Anxiety
Active Not RecruitingNCT06991023
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 25 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- University of Reading
- Condition
- Anxiety
Active Not RecruitingNCT06899607
This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 18 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- University of Reading
- Condition
- Anxiety
CompletedNCT04953338
This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Momentum Data
- Condition
- Depression
CompletedNCT05145413
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, India, Japan, Poland, Romania, Serbia, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia